Heparanase-specific shRNA: A novel therapeutic strategy in human gastric cancer
Wednesday, November 25, 2009 - 12:21
in Health & Medicine
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.